Last reviewed · How we verify
THERACAL LC
THERACAL LC is a calcium hydroxide-based liner that releases calcium ions to promote remineralization and provide antimicrobial protection in dental cavities.
THERACAL LC is a calcium hydroxide-based liner that releases calcium ions to promote remineralization and provide antimicrobial protection in dental cavities. Used for Cavity liner for deep carious lesions, Pulp protection under composite restorations, Dentin desensitization.
At a glance
| Generic name | THERACAL LC |
|---|---|
| Also known as | resin-based calcium silicate cement, Resin-modified calcium silicate |
| Sponsor | DR SURINDER SACHDEVA |
| Drug class | Dental liner/base material |
| Modality | Small molecule |
| Therapeutic area | Dentistry |
| Phase | FDA-approved |
Mechanism of action
THERACAL LC is a light-curable calcium hydroxide liner used in restorative dentistry. It functions by releasing calcium hydroxide, which stimulates secondary dentin formation, neutralizes bacterial acids, and provides antimicrobial activity. The material sets when exposed to visible light, allowing for precise application and immediate restoration placement.
Approved indications
- Cavity liner for deep carious lesions
- Pulp protection under composite restorations
- Dentin desensitization
Common side effects
Key clinical trials
- Evaluation of Regenerative Endodontic Treatment for Immature Teeth (NA)
- Comparison of Hyaluronic Acid, TheraCal, and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars (NA)
- A Comparative Study of Different Traditional and Bioactive Indirect Pulp Capping Materials (NA)
- Comparative Evaluation of the Clinical Outcome of Direct Pulp Capping Treatment in Permanent Molars (NA)
- Direct Pulp Capping Agent on Human Pulp Tissue (PHASE4)
- Clinical Investigation of Effectiveness of a Calcium Silicate Cement (NA)
- Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions (PHASE2, PHASE3)
- TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |